CV
Cadrenal Therapeutics, Inc. Common Stock (CVKD)
NASDAQ·Healthcare·Biotechnology
$1.09
-8.47%
Mkt Cap $3.89M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$32.00
Range $32.00 – $32.00
Implied Upside
+2835.8%
Consensus $32.00 vs current $1.09